Bob Dagher
Directeur Technique/Scientifique/R&D chez BRAINSTORM CELL THERAPEUTICS INC.
Fortune : 123 211 $ au 31/05/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Irit Arbel | M | 64 | 24 ans | |
| Uri Yablonka | M | 47 | 10 ans | |
| Michael Webb | M | 66 | 2 ans | |
| Stacy Lindborg | M | 53 | 4 ans | |
| Jacob Frenkel | M | 81 | 4 ans | |
| Frank Pasqualone | M | 68 | 2 ans | |
| Chaim Lebovits | M | 53 | 17 ans | |
| Menghisteab Bairu | M | 63 | 3 ans | |
| Yael Gothelf | M | - | 17 ans | |
| Alla Patlis | F | 37 | 12 ans | |
| Anthony Polverino | M | 61 | 6 ans | |
| Nir Naor | M | 49 | 1 ans | |
| Yossef Levy | M | - | - | |
| Mary Kay Turner | F | - | 7 ans | |
| Netta Blondheim-Shraga | M | - | 2 ans | |
| Antal Pearl-Lendner | F | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| June Almenoff | M | 67 | 6 ans | |
| Jodie Morrison | F | 48 |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 ans |
| Michael Brooks | M | 50 | 2 ans | |
| Steve Innaimo | M | - | 1 ans | |
| Bevin O’Neil | M | - | - | |
| Bradley Thompson | M | 67 | 1 ans | |
| David Ian Johnson | M | 66 | 1 ans | |
| Dave Grayzel | M | 56 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| John McBride | M | 72 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 2 ans |
| James Bristol | M | 77 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 10 ans |
| Carter Ward | M | 59 | 1 ans | |
| Robert Dickey | M | 68 | 1 ans | |
| Mark Gelder | M | 67 | 2 ans | |
| Jonathan Zung | M | 59 | 2 ans | |
| Kirk Taylor | M | - | - | |
| James Harkness | M | 59 | 3 ans | |
| Paul Kirchgraber | M | 62 | - | |
| Xiao Ning Guo | M | 46 | 4 ans | |
| Christopher Kenney | M | 53 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 1 ans |
| Timothy Piser | M | - |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | 6 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 36 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Bob Dagher
- Réseau Personnel
